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Hepatitis E
Antibodies in
Laboratory Rabbits
from 2 US Vendors

supplier), and 3) HEV seroprevalence might confound research. To investigate the latter hypothesis, we retrospectively analyzed records from a subset of animals used in a
herpes simplex 1 virus (HSV-1) research project.

Leslie Birke, Stephania A. Cormier,
Dahui You, Rhett W. Stout, Christian Clement,
Merlin Johnson, and Hilary Thompson

Two shipments of New Zealand White rabbits (70 rabbits shipment 1 [rabbit nos. AN1–AN20 and AH1–AH30]
in June 2012 to Louisiana State University Health Sciences
Center [LSUHSC]; shipment 2 [rabbit nos. AH31–AH51]
in October 2012) were obtained from supplier A at LSUHSC. Supplier A also provides rabbits to the meat production industry. A third shipment comprising 10 Dutch Belted
SPF rabbits (nos. DB1–DB10) were obtained from supplier
B in August 2012 at LSUHSC. Supplier B rabbits were
SPF for Pasturella multocida, Pasturella pneumotropica,
Bordetella brochiseptica, Treponema cuniculi, Clostridium piliformis, cilia-associated respiratory bacillus, Salmonella spp., Encephalitozoon cuniculi, Eimeria stiedae,
Eimeria magna, Eimeria intestinalis, Eimeria irresidua,
Eimeria flavescens, Eimeria piriformis, Toxoplasma gondii, Passalurus ambiguous, other helminths, parainfluenza
virus 1, parainfluenza virus 2, reovirus, Psoroptes cuniculi,
Cheyletiella parasitovorax, Leporacarus gibbus, and Dermatomycosis spp.
The rabbits’ care and use were approved by the
LSUHSC Institutional Animal Care and Use Committee and were consistent with the Guide for the Care and
Use of Laboratory Animals (8) and the Animal Welfare
Act (http://www.aphis.usda.gov/animal_welfare/). The
LSUHSC is fully accredited by American Association
for the Assessment of Laboratory Animal Care, Int. The
animals were singly housed in stainless steel rabbit cages
(Suburban Surgical, Wheeling, IL, USA). On the day the
rabbits arrived, blood was collected from each rabbit and
stored for HEV testing. Rabbits from vendor A were treated for P. cuniculi and L. gibbus with selamectin (Pfizer
New York, NY, USA). After arrival, the rabbits were acclimated to the facility for 7 days. After this period, they
were used for research protocols approved by the Institutional Animal Care and Use Committee.

We tested laboratory rabbits from 2 US vendors for
antibodies against hepatitis E virus (HEV); Seroprevalences were 40% and 50%. Retrospective analysis of an
ocular herpes simplex 1 experiment demonstrated that HEV
seropositivity had no effect on experiment outcome. HEV
probably is widespread in research rabbits, but effects on
research remain unknown.

H

epatitis E virus (HEV) is a single-stranded RNA virus in the family Hepeviridae (1). HEV is transmitted
through the fecal–oral and bloodborne routes and typically
causes transient hepatitis; however, such infections can be
fatal, especially in pregnant women (20% mortality rate)
and in immunocompromised persons (2,3).
HEV has 4 genotypes, and genotypes 3 and 4 are found
in humans and other animals (1). The genomic sequence
of US rabbit HEV (GenBank accession no. JX565469) has
been analyzed and the sequence places rabbit HEV as a distant member of the zoonotic HEV genotype 3 (4). A study in
France found HEV in farmed and wild rabbits and characterized a closely related human strain of HEV (5). Although
HEV has been detected in rabbits from Asian and European
counties, researchers previously thought that HEV was not
a major presence in rabbits in the United States (5–7). A recent study identified a 36% prevalence of HEV antibodies
in animals on 2 rabbit farms in Virginia (1).
Because HEV may be a confounding factor in research
and is a potential zoonotic pathogen (5), we tested rabbits
from 2 US suppliers for HEV seroprevalence. Supplier A
was a local conventional rabbit farm, and supplier B was
a commercial vendor of specific pathogen free (SPF) research rabbits. Our hypothesis was 3-fold: 1)HEV is a possibly undiagnosed pathogen in laboratory rabbits, 2) HEV
seroprevalence is unlikely in rabbits from supplier B (a SPF
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The Study
Animals

Sample Collection

Approximately 0.5–1 mL of blood was collected
through the rabbits’ middle auricular artery with a 25-gauge
butterfly catheter. The blood was placed into serum separator tubes for centrifugation. Serum was then placed into
microcentrifuge tubes and stored at –20°C until analysis.
Laboratory personnel changed gloves between blood collection from each rabbit and between contact with each
sample when transferring serum.
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Figure 1. Hepatitis E virus antibody detection for rabbits from supplier A, shipment 1 (June 2012, Louisiana State University Health
Sciences Center). Rabbits were purchased from supplier A. Serum was isolated and antibodies in the serum were measured by using
ELISA. Rabbit identification numbers are listed on the x-axis and the mean + SD optical density of each sample is listed on the y-axis.
The negative cutoff point is indicated by the horizontal line. +, positive control.

HEV Infection and Outcome of Rabbit Model
of Ocular HSV-1

The records of 30 animals from supplier A (AH1–
AH30) were obtained retrospectively from an investigator
who used the rabbits in an HSV-1 ocular keratitis study.
Survival data and HEV antibody status were examined statistically to determine whether HEV status had any effect
on the survival of the rabbits in the study. Briefly, 4 different strains of HSV-1 with different virulence levels were

tested, including MCK D-gK, ICP0-delete, 17 syn + mutant, and McKrae. Rabbits were infected with these viruses,
and keratitis score and survival rate were recorded.
ELISA

ELISA was performed by using the protocol from
Cossaboom et al. with a few modifications (1). Plates
(Fischer Scientific, Waltham, MA, USA) were coated with
6 µg HEV antigen (Clone# rHEV-ORF2; Feldan Bio Inc.,

Figure 2. Hepatitis E virus antibody detection for rabbits from suppliers A and B, shipments 2 (October 2012, Louisiana State University
Health Sciences Center [LSUHSC]) and 3 (8/2012 LSUHSC). Rabbits were purchased from supplier A (gray bars) and supplier B (black
bars). Serum was isolated and antibodies in the serum were measured by using ELISA. Rabbit identification numbers are listed on the
x-axis and the mean + SD optical density of each sample is listed on the y-axis. The negative cutoff point is indicated by the horizontal
line. White bars indicate controls. +, positive control; –, negative control.
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Quebec, QC, Canada), incubated with 100 µL of rabbit serum diluted 10-fold in blocking buffer, and detected with
horseradish peroxidase–conjugated secondary antibody
(goat anti–rabbit IgG diluted 1:1000, Southern Biotech,
Birmingham, AL, USA). The plates were read at 450 nm
and 540 nm for correction on a SpectraMax M2 plate reader (Molecular Devices, Sunnyvale, CA, USA).
Statistical Analysis

ELISAs for HEV were performed in duplicate on
each serum sample, and the results were averaged. A
1-way analysis of variance was performed to find the optical densities that were not statistically different from
those of the negative controls. The values of the negative controls and the negative samples were then used to
determine the cutoff points for the ELISA (mean of the
negative samples + 3 SDs).
To evaluate the possible effect of HEV serology status on the survival of rabbits used in the HSV-1 study, we
used the Fisher exact test when HSV-1 survival status was
cross-tabulated with the HEV serology status. Odds ratios
are also reported (SAS, version 9.3, SAS Institute, Cary,
NC, USA); α was set at 0.05.
Prevalence of HEV in US Laboratory Rabbits

We found that the seroprevalence of HEV in the 70
rabbits from supplier A was 40%. The 10 rabbits from supplier B exhibited a 50% seroprevalence for HEV (Figures
1 and 2).
HEV Infection and Disease Outcome of
HSV-1–infected Animals

HSV-1 outcome results revealed no significant association between positive serologic HEV status and frequency of HSV-1 signs. Prevalence of positive HEV status
was 32% (6/19) , compared with 36% (4/11) (p = 0.298,
odds ratio 1.238, 95% CI 0.2592–5.9132) for frequency of
HSV-1 signs.
Conclusions
We sought to determine the seroprevalence of HEV
in research rabbits within LSUHSC. We were surprised to
identify HEV-seropositive rabbits from the SPF research
rabbit supplier (supplier B) because of the strict health
quality standards employed at this supplier. The difference
in HEV seroprevalence between the 2 vendors may be a
function of sample numbers. Testing a larger number of
samples from supplier B would answer this question. HEV
may be widespread in research facilities throughout the
United States.
Statistically, we could not demonstrate any effect of
HEV serology status on the survival outcome or keratitis scores of HSV-1–infected rabbits. However, the

interpretation of these results is limited because only
tested for HEV only by serologic testing and not reverse
transcription PCR. Controlled studies in which rabbits
are experimentally infected with HEV and then later infected with another pathogen are needed to determine
the true effects of HEV co-infection on the outcome of
systemic infection experiments in rabbits.
Rabbits are commonly used in research and they
often housed in a conventional setting. Because HEV is
classified as a Biosafety Level-2 pathogen, wearing personnel protective protection equipment, such as masks,
laboratory coats, and gloves, when working with rabbits
is warranted (9,10). Laboratory animal care personnel, researchers, and support staff represent a new population at
risk for HEV infection, and research facilities should be
diligent in measures to prevention of this possibly zoonotic pathogen.
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